COVID-19 trials registries data warehouse

http://ensaiosclinicos.gov.br/rg/RBR-2mfbkkk

Letícia Parreira

lfsparreira@icloud.com

2022-03-07

Not recruiting

RCT

Randomized

Parallel

Open label

single-center

Long covid

Tested positive for coronavirus (COVID-19) after the Reverse Transcriptase Reaction followed by Polymerase Chain Reaction (RT-PCR) examination and who complained of symptoms of dysgeusia, Patients aged 18 years or older, Patients who are not in the disease transmission phase (fifteen days after the onset of symptoms), Patients who accept to be part of the research by signing the Free and Informed Consent Term, Patients who underwent gustatory dysfunction assessment tests and dysgeusia was confirmed

Patients who tested negative for coronavirus (COVID-19) after the Reverse Transcriptase Reaction followed by Polymerase Chain Reaction (RT-PCR) test, No complaints of dysgeusia symptoms, Under 18 years old, Pregnant and/or lactating patients, Patients who do not accept to participate in the research or who do not sign the Free and Informed Consent Form

2

Pontifícia Universidade Católica de Campinas

18

100

Brazil

Patients recovered from covid

N/A

0

It is expected that; with the application of a non-invasive therapy with low intensity laser; which will consist of the systemic photoactivation of the carotid artery and the photobiomodulation of the taste buds and salivary glands; it will present results of reducing the manifestation of dysgeusia as a sequel of the coronavirus (COVID-19).

Not reported

[{"arm_notes": "", "treatment_id": 2385, "treatment_name": "Light therapy", "treatment_type": "Medical device", "pharmacological_treatment": "Non pharmacological treatment"}, {"arm_notes": "", "treatment_id": 2187, "treatment_name": "Placebo", "treatment_type": "Placebo", "pharmacological_treatment": "Placebo"}]